Skip navigation
All CNBC  |  News  |  Video


Sector: Pharmaceuticals
Wednesday, 28 Oct 2009 | Source: CNBC.com
Stocksskidded Wednesday, despite a rise in durable-goods orders and some earnings beats, as worries about the recovery dragged on the market.
Wednesday, 28 Oct 2009 | Source: CNBC.com
The weak consumer confidence report that hit U.S. stocks on Tuesday is having a lingering effect this Wednesday, with global stock markets falling and stock index futures pointing to another lower open on Wall Street.
Thursday, 22 Oct 2009 | Posted By: Mike Huckman | Source: CNBC.com
A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.
Wednesday, 21 Oct 2009 | Source: CNBC.com
Amgen reported quarterly results that outpaced what Wall Street was expecting, and the company boosted its outlook for its full-year profit. But the company's shares declined in extended trading.
Tuesday, 20 Oct 2009 | Source: CNBC.com
Pfizer's acquisition of Wyeth will add to the pharmaceutical giant's diversity, which over time will help boost the company's stock, CEO Jeff Kindler told CNBC Tuesday.
Friday, 16 Oct 2009 | Posted By: Cindy Perman | Source: CNBC.com
Stocks pared some of their earlier losses but were still lower as disappointing results from Bank of America and General Electric eclipsed strong results from big techs.
Friday, 16 Oct 2009 | Posted By: Cindy Perman | Source: CNBC.com
Stocks pared some of their earlier losses but were still lower as disappointing results from Bank of America and General Electric eclipsed strong results from big techs.
Friday, 16 Oct 2009 | Source: CNBC.com
Stocks skidded at the open Friday as disappointing results from Bank of America and General Electric eclipsed strong results from big techs. They slid further — with the Dow down 100 points — after a report showed a surprise drop in consumer sentiment.
Friday, 16 Oct 2009 | Source: CNBC.com
Futures indicated a lower open for Wall Street Friday, as mixed earnings from General Electric eclipsed strong results from big techs.
Thursday, 15 Oct 2009 | Posted By: Cindy Perman | Source: CNBC.com
The Dow pulled off a nearly 50-point  gain Thursday after a topsy-turvy session as the boost from oil's rally ultimately beat out disappointment in earnings from Goldman Sachs and Citigroup.
Thursday, 15 Oct 2009 | Source: CNBC.com
Traders applied the brakes Thursday, a day after the Dow topped 10,000, as Goldman Sachs and Citigroup proved no match for Wall Street's inflated earnings expectations.
Thursday, 15 Oct 2009 | Source: CNBC.com
Stocks pared their losses Thursday after a third straight positive Philly Fed reading — the first time that's happened in two years.  Stocks had opened lower after disappointment in earnings from Goldman Sachs and Citigroup.
Thursday, 15 Oct 2009 | Source: CNBC.com
After Wednesday's stellar market performance, stock index futures indicated a lower open for Wall Street on Thursday as investors take a breather and evaluate their next move.
Wednesday, 14 Oct 2009 | Posted By: Cindy Perman | Source: CNBC.com
Stocks rallied Wednesday and the Dow broke through 10,000 for the first time in over a year, fueled by strong earnings from JPMorgan and Intel.
Wednesday, 14 Oct 2009 | Source: CNBC.com
Stocks rallied Wednesday, with the Dow homing in on 10,000, after JPMorgan and Intel got earnings season back on track and retail sales fell less than expected.
Previous|Next
Posts |  SECTOR : Health
Pfizer today announced it's paying what amounts to chump change (a total of $115 million over time) for the rights to a biotech drug to treat a rare disease... Read More
24 Nov 2009
For the second time in three weeks I'm at a flu vaccine manufacturing plant today... Read More
23 Nov 2009
With the health care debate continuing, how can investors make money in the sector? Barbara Ryan, managing director and senior pharmaceuticals analyst at Deutsche Bank Securities, and Charles Boorady, health care providers analyst at Citigroup, shared their insights.... Read More
20 Nov 2009
Investors, patients and activists, no doubt, hope they won't have to put out a mayday distress call, but as Dendrama's fate would have it, the company announced today that the Food and Drug Administration has assigned May Day as its decision day for the prostate cancer treatment Provenge.... Read More


Current DateTime: 02:18:31 01 Dec 2009
LinksList Documentid: 23188555



Current DateTime: 02:18:31 01 Dec 2009
LinksList Documentid: 23188557

Current DateTime: 01:32:02 01 Dec 2009
LinksList Documentid: 29778428

Current DateTime: 01:04:14 01 Dec 2009
LinksList Documentid: 29779196

Current DateTime: 10:29:59 01 Dec 2009
LinksList Documentid: 29779199

Current DateTime: 07:24:10 01 Dec 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters